Role of Enteral Nutrition in Neoadjuvant Therapy for Locally Advanced Gastric Cancer with Pyloric Obstruction: A Case Series
Abstract
Objective: To evaluate whether neoadjuvant therapy can be carried out in pyloric obstruction secondary to gastric cancer through nasojejunal enteral nutrition and assess tumor regression and improvement in surgical outcomes.
Material and Methods: A retrospective cohort analysis of patients diagnosed with locally advanced gastric cancer (LAGC) with pyloric obstruction who received preoperative nutritional support via nasojejunal tube feeding. Once nutritional adequacy was achieved, patients proceeded to neoadjuvant therapy consisting of S-1 plus oxaliplatin (SOX chemotherapy), targeted therapy with apatinib, and immunotherapy with sintilimab. Tumor and lymph node responses were assessed radiologically and confirmed by postoperative pathological analysis.
Results: Enteral feeding was well tolerated without major complications, and all patients were able to complete the neoadjuvant regimen. Imaging showed dramatic shrinkage of the tumor mass and regression of regional lymph node enlargement. After surgery, certain cases yielded a result of complete tumor regression (Tumor Regression Grade 0) in the pathology, including resolution of lymph node metastases. Clinical results established that nutritional optimization helped in the effective downstaging of tumors and thus improved the chances of R0 resection.
Conclusion: Nasoenteric enteral nutrition is a feasible and effective method to enable the safe delivery of neoadjuvant therapy in patients with pyloric obstruction resulting from gastric cancer. It optimizes nutrition, enhances treatment tolerance, and contributes to favorable oncologic outcomes.
Keywords
Full Text:
PDFReferences
Ye W, Dong B, Li G, Zhang Y. The effect of probiotics on surgical outcomes in patients with gastric cancer: a meta-analysis of randomized controlled trials. Frontiers Surg 2023;10:1254597.
Bering J, DiBaise JK. Home parenteral and enteral nutrition. Nutrients 2022;14:2558.
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NE, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 2017;36:1187-96.
Park YS, Park DJ, Kim KH, Park DJ, Lee Y, Park KB, et al. Nutritional safety of oncometabolic surgery for early gastric cancer patients: a prospective single-arm pilot study using a historical control group for comparison. Surg Endosc 2020;34:275-83.
Albain KS, Barlow WE, Shak S. Bibliography current world literature. Ann Oncol 2010;21:238-44.
Oshima T, Yoshikawa T, Miyagi Y, Morita S, Yamamoto M, Tanabe K, et al. Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: an exploratory biomarker study of COMPASS, a randomized phase II trial. Oncotarget 2020;11:2906-18.
Kono K, Nakajima S, Mimura K. Biomarker-oriented chemo-immunotherapy for advanced gastric cancer. Int J Clin Oncol 2024;29:865-72.
Li XQ, Zhao ZL, Hou ML, Cui YX, Han SY, Fu FF. The influence of cachexia on the immunotherapy efficacy of sintilimab for non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 2021;43:1292-7.
Li W, Wei J, Cheng M, Liu M. Unveiling promising targets in gastric cancer therapy: a comprehensive review. Mol Ther Oncolytics 2024; Mol Ther Oncolytics 2024;32:200857.
Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003;98:1521-30. doi: 10.1002/cncr.11660.
Sihag S, Merritt RE, eds. Contemporary management of esophageal and gastric cancer. Surg Oncol Clin N Am 2024;33:xv-xvi.
Catenacci DV, Chao J, Muro K, Al-Batran SE, Klempner SJ, Wainberg ZA, et al. Toward a treatment sequencing strategy: a systematic review of treatment regimens in advanced gastric cancer/gastroesophageal junction adenocarcinoma. Oncologist 2021;26:e1704-29.
Zhang Z, Liu N, Sun M. Research progress of immunotherapy for gastric cancer. Technol Cancer Res Treat 2023;22: 15330338221150555.
Lassen K, Soop M, Nygren J, Cox PB, Hendry PO, Spies C, et al. Consensus review of optimal perioperative care in colorectal surgery: enhanced recovery after surgery (ERAS) Group recommendations. Arch Surg 2009;144:961-9.
Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, et al. Assessment of nutritional status and analytical methods. Exerc Sport Sci Rev 2006;34:10-5.
Aktan I, La Ragione RM, Woodward MJ, Ando H, Abe H, Sugimoto N, et al. Gastrointestinal infections. Microbiology 2007;153:464-73.
Abou-Ashour HS, El Kased AF, Elsisi AA, Abdelrazek E, Youssef FI, Shahin MA. Impact of preoperative nutritional support on patients with gastric cancer surgery. Egypt J Surg 2022;41:165-72.
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 2017;36:1187-96. doi: 10.1016/j.clnu.2017.06.017.
Leroux C, Konstantinidou G. Targeted therapies for pancreatic cancer: overview of current treatments and new opportunities for personalized oncology. Cancers 2021;13:799.
Xin C, Wang Y, Luo Y, Gai Y, Han B. Effect of perioperative immunonutrition on outcomes in gastric cancer surgery patients: a systematic review and evidence map. Clin Nutr ESPEN 2025;10:55-63.
Zeng X, Wang HY, Bai SY, Pu K, Wang YP, Zhou YN. The roles of microRNAs in multidrug-resistance mechanisms in gastric cancer. Curr Mol Med 2020;20:667-74.
Yu Z, Tu H, Qiu S, Dong X, Zhang Y, Ma C, et al. Multidisciplinary treatment for locally advanced gastric cancer: a systematic review and network meta-analysis. J Minim Access Surg 2023;19:335-47.
Kobayashi T, Iwama S, Yasuda Y, Okada N, Okuji T, Ito M, et al. Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study. J Immunother Cancer 2020;8:e000779.
de Araújo LL, Barbosa JM, Ribeiro AG, dos Santos AO, Pedrosa F. Nutritional status, dietary intake and serum levels of vitamin C upon diagnosis of cancer in children and adolescents. Nutr Hosp 2012;27:204-11.
Sagawa M, Matsui R, Sano A, Sakai M, Hiraoka S, Tabei I, et al. Perioperative nutrition therapy for patients with head and neck or gastrointestinal cancer: a systematic review and meta-analysis. Clin Nutr ESPEN 2025;67:567-77.
Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci 2021;22:4496.
Kim KW, Lee K, Lee JB, Park T, Khang S, Jeong H, et al. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study. BMC Cancer 2021;21:1-8.
Wu J, Deng R, Ni T, Zhong Q, Tang F, Li Y, et al. Efficacy and safety of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for locally advanced stages of esophageal cancer: a systematic review and meta-analysis. Front Oncol 2022;12:887525.
Li YN, Xie B, Zhang Y, He MH, Xing Y, Mu DM, et al. Advances and key focus areas in gastric cancer immunotherapy: a comprehensive scientometric and clinical trial review (1999–2023). World J Gastroenterol 2023;29:5593-612.
Li P, Li Z, Linghu E, Ji J, Society of Digestive Endoscopy of the Chinese Medical Association, Colorectal Surgery Group of the Chinese Medical Association, et al. Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer. Chin Med J 2024;137:887-908.
Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese Society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun 2021;41:747-95.
Li XQ, Liang Y, Huang CF, Li SN, Cheng L, You C, et al. Advancements in nutritional diagnosis and support strategies during the perioperative period for patients with liver cancer. World J Gastrointest Surg 2024;16:2409.
Wang C, Yang D. Effect of different preoperative nutritional treatments on postoperative recovery and clinical outcomes in patients with gastric cancer and early gastric outlet obstruction. Oncol Lett 2024;27:214-21.
Zhao J, Wang G, Jiang ZW, Jiang CW, Liu J, Xia CC, et al. Patients administered neoadjuvant chemotherapy could be enrolled into an enhanced recovery after surgery program for locally advanced gastric cancer. Chin Med J 2018;131:413-9.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.